Browsing Tag
SPARC
4 posts
SPARC (NSE: SPARC) and ABFRL (NSE: ABFRL) lead top Indian stock losers as pharma, retail, and NBFCs weaken
SPARC, ABFRL, and Agro Phos led Indian stock market losers on June 4, 2025, as drug trial failures, bulk exits, and sector-wide pressures rattled investors.
June 5, 2025
Sun Pharmaceutical gets SEZABY FDA approval for neonatal seizures
Sun Pharmaceutical Industries has secured approval for SEZABY (phenobarbital sodium powder for injection) from the US Food and…
November 18, 2022
SPARC signs licensing deal with Visiox for two ophthalmic drug candidates
Sun Pharma Advanced Research Company (SPARC) has signed a licensing agreement with Visiox Pharma to award exclusive worldwide…
December 8, 2021
Sun Pharma Advanced Research signs licensing deal with Biomodifying
Sun Pharma Advanced Research Company (SPARC) has signed an agreement with US-based Biomodifying for the exclusive licensing of…
December 4, 2021